www.gavi.org Gavi?s 2016 - 2020 private sector engagement approach SCALING INNOVATION FOR IMPACT Gavi Board technical briefing session 21 June 2016 | Geneva, Switzerland Reaching further, together A HISTORY OF CREATING SHARED VALUE PUBLIC PRIVATE PARTNERSHIP WITH VACCINE MANUFACTURERS VACCINE PRICE Total cost to immunise a child with pentavalent, pneumococcal and rotavirus vaccines (US$) DIVERSIFICATION Number of vaccine manufacturers *Future targets are not publicised to avoid setting a minimum price . Source: UNICEF Supply Division, 2016. $35 $33 $23 $22 $22 $20 2010 Baseline 2011 2012 2013 2014 2015 5 2001 2015 16 Manufacturers in 11 countries Manufacturers in 5 countries SHIFTING MINDSET Of vaccine manufacturers by pooling country demand
G avi Alliance Board Meeting 22 -23 June 2016 Starling Hotel, Geneva, Switzerland Monday 20 and Tuesday 21 June: Pre -Board meetings Wednesday 22 June: 0 8.30 -18.00 (Board meeting Day One) Thursday 23 June: 09.00 -16.45 (Board meeting Day Two) Quorum: 1 4 Document list Pack 1 Pack 2 Document 00a Document list 00b 00b Agenda 01a Declarations of interest 01b Minutes from 2-3 December 2015 01c Workplan including 2017 Board meeting dates 02a Consent agenda: Board/Committee member appointments (To follow) 02b Consent agenda: Board Travel Policy review 02c Consent agenda: Gavi Alliance ad -hoc appeals tribunal (To follow) 02d Consent agenda: Programme funding request ? new vaccine support 02e Consent agenda: Oral Cholera Vaccines operationa l cost support 02f Consent agenda: Men A bridg e funding 02g Consent agenda: Co -financing of Japanese Encephalitis vaccine 03 2016 -2020 Strategy: Implementation and progress - No paper 04 CEO?s report (To follow) 05 Committee Chair and IFFIm Board reports ? No paper 06 Gavi -Global Fund approach to collaboration 07 Financial update 08 Report from Audit and Investigations 09 Malaria vaccine pilots 09 Appendix Malaria vaccine pilots ? PPC Paper 10 Chair?s reflections on the day ? No paper 11 Chair?s overview ? No paper 12 Health system and immunisation strengthening support 12 Appendix Health system and immunisation strengthening support ? PPC Paper + Annexes A , B & C 13 Partners? Engagement Framework & Alliance Accountability Frame work 14 Country Programmes: Sustaining Immunisation Gains ? No paper 15 Supply and procurement strategy 2016 -2020 15 Appendix Supply and procurement strategy 2016 -2020 ? PPC Paper + Annex A & B 16 Review of decisions ? No paper 17 Any other busin ess ? No paper 18 Board and Committee minutes (For information only)
G avi Alliance Board Meeting 22 -23 June 2016 Starling Hotel, Geneva, Switzerland
Monday 20 and Tuesday 21 June : Pre -Board meetings Wednesday 22 June : 0 8.30 -18. 00 (Board meeting Day One) Thursday 23 June : 0 9.00 -16.45 (Board meeting Day Two) Quorum: 14
Agenda
Pre -Board Meetings ? Monday, 20 June 2016 Item Subject Room Schedule
Declarations Section 5.2 of the Conflict of Interest Policy stat es, ?Annually, each member of the Board (including alternate Board members and Committee de legates)...shall complete and submit a conflict of interest form to be distributed by the Managing Director, Law and Governance.? The following declarations were made by members of the Board on their most recent annual statements:
Board members: Member Organisational Interests Financial/Personal/Advisor Int Ngozi Okonjo-Iweala, Chair None Gavi-appointed special adviser Flavia Bustreo, Vice Chair WHO Gavi-appointed special adviser Gunilla Carlsson None None H.R.H. the Infanta Cristina of Spain None la Caixa? Foundation (Employee) Barcelona Inst. for Global Health (Board) Aga Khan Dev.Network (Employee) Yifei Li None Man Group (Country Chair) Rockefeller Foundation (Board) Sania Nishtar None None William H. Roedy None None Richard Sezibera None Gavi-appointed special adviser David Sidwell None None Stephen Zinser None None Orin Levine Bill & Melinda Gates Foundation PATH (Family) Tim Evans The World Bank None Geeta Rao Gupta UNICEF None Seif Seleman Rashid Government of Tanzania Gavi-appointed special adviser Khagaraj Adhikari SEARO and WPRO countries Gavi-appointed special adviser Bahar Idriss Abugarda Government of Sudan Gavi-appointed special adviser Edna Yolani Batres Government of Honduras Gavi-appointed special adviser Raymonde Goudou Coffie Government of Cote d?Ivoire Gavi-appointed special adviser Ingrid Gabriela Hoven GER (EC/FRA/GER/LUX) None
IMMUNISATION ON THE GLOBAL AGENDA RESULTS UPDATE DELIVERING ON THE NEW STRATEGY CEO Board presentation Seth Berkley MD, 22 June 2016 TRANSITION Gavi 3.0 Gavi 4.0 IMMUNISATION ON THE GLOBAL AGENDA RESULTS UPDATE DELIVERING ON THE NEW STRATEGY IMMUNISATION ON THE GLOBAL AGENDA IMMUNISATION ON THE GLOBAL AGENDA Board meeting22-23 June 2016
www.gavi.org Evaluation Advisory Committee Chair Report BOARD MEETING Rob Moodie 22 -23 June 2016 Outline ? Ongoing evaluation work to inform priority areas 1. Full Country Evaluations 2. Technical Assistance evaluation 3. HSIS review: designing the evaluation approach ? Use of findings of completed evaluations ? Outcomes & Impact Advance Market Commitment evaluation ? Albania end of Gavi support evaluation Board meeting22-23 June 2016
IFFIm update The International Finance Facility for Immunisation Ren? Karsenti, Chair IFFIm Board of Directors 22 June 2016 | Geneva 1. Funding Gavi 2. IFFIm?s continued strategic role 3. Replicating IFFIm for Global Goals 2
Strengthening Immunization Programs - Building Health Systems Gavi / WBG Partnership on Institutional & Financial Sustainability Gavi Board Meeting, June 22, 2016 ? a win -win relationship for sustained results ? Strengthening immunization programs Building health systems 2
Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016 Update on Transition: the case of Honduras GAVI Support for Honduras Honduras EPI Situation 2011 -2016 Vaccination Scheme and New Vaccine Introduction Focus of Engagement during Transition Phase Post - Transition Prospects Content
